INNATE PHARMA: cashflow_investing
| Value | {"amount": 1877000.0, "concept": "ifrs-full:CashFlowsFromUsedInInvestingActivities"} |
|---|---|
| Period | 2022-01-01 – 2022-12-31 |
| Status | current |
| Entity | INNATE PHARMA |
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
Retrieved: 2026-08-24T00:10:15.202100+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/ce46bce6-4f5d-436f-86fb-5da1c627bcb4
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
esef:9695002Y8420ZB8HJE29:2023-12-31Retrieved: 2026-08-24T00:10:15.202100+02:00
Raw response sha256:
8cc6e40d8d62bf3f280603498c300fb9…Cite as: FACTANKER, https://factanker.com/fact/ce46bce6-4f5d-436f-86fb-5da1c627bcb4
History
- no predecessors — first report